(Q39583643)

13 September 2017

title

The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells (English)

1 reference

13 September 2017

1 reference

Fu-Ning Hsu

1

1 reference

13 September 2017

Min-Shiou Yang

2

1 reference

13 September 2017

Eugene Lin

3

1 reference

13 September 2017

Chun-Fu Tseng

4

1 reference

13 September 2017

Ho Lin

5

1 reference

13 September 2017

publication date

1 March 2011

1 reference

American Journal of Physiology - Endocrinology and Metabolism

13 September 2017

published in

1 reference

13 September 2017

volume

300

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

E902-8

1 reference

Androgen-dependent regulation of Her-2/neu in prostate cancer cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Androgen axis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Molecular biology of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Androgen receptor outwits prostate cancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Her-2/neu oncogene amplification in clinically localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Human prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00610.2010

10.1152/AJPENDO.00610.2010

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference